US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Hopening (MLHPE) 銘柄情報

Hopening (MLHPE)

5.45

0.00

(0.00%)

終了 6月7日 12:30AM

Hopening (MLHPE) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

5.45

( - )

買値

5.45

売値

5.45

出来高

0.00

0.00 日の範囲 0.00

5.20 52 週間の範囲 7.75

時価総額

前日終値

5.45

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

95 €

発行済株式数

720,957

配当利回り

(6.46%)

PER

-

1 株当たり利益 (EPS)

-

歳入

15.5M

純利益

350.98k

Hopening SA, together with its subsidiaries, engages in fundraising, sponsorship, and philanthropy services in France. It offers relationship marketing, digital marketing, mobilization communication, philanthropy and corporate sponsorship, data science and DB, innovation, acquisition issued, and leg... Hopening SA, together with its subsidiaries, engages in fundraising, sponsorship, and philanthropy services in France. It offers relationship marketing, digital marketing, mobilization communication, philanthropy and corporate sponsorship, data science and DB, innovation, acquisition issued, and legacy and gifts strategies. The company was formerly known as Optimus S.A. and changed its name to Hopening SA in March 2017. Hopening SA was incorporated in 1989 and is based in Puteaux, France. 詳細を表示

セクター

Media

業界

Traditional Media

ウェブサイト

hopening.fr

本社

Puteaux, France

設立

1989

Hopening is listed in the Media sector of the ユーロネクスト with ticker MLHPE. The last closing price for Hopening was 5.45 €. Over the last year, Hopening shares have traded in a share price range of 5.20 € to 7.75 €.

Hopening currently has 720,957 shares in issue. The market capitalisation of Hopening is 3.93 € million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.05	-0.909090909091	5.5	5.5	5.3	1	5.4125	DE
4	0.15	2.83018867925	5.3	5.5	5.3	1	5.44583333	DE
12	-0.15	-2.67857142857	5.6	6.2	5.25	20	5.41396926	DE
26	-1.05	-16.1538461538	6.5	6.5	5.2	18	5.54767271	DE
52	-1.55	-22.1428571429	7	7.75	5.2	21	6.11480441	DE
156	-0.55	-9.16666666667	6	10	5.2	16	7.06452005	DE
260	1.95	55.7142857143	3.5	10	3.4	16	5.98117013	DE

MLHPE - Frequently Asked Questions (FAQ)

What is the current Hopening share price?

The current share price of Hopening is 5.45 €

How many Hopening shares are in issue?

Hopening has 720,957 shares in issue

What is the market cap of Hopening?

The market capitalisation of Hopening is EUR 3.93M

What is the 1 year trading range for Hopening share price?

Hopening has traded in the range of 5.20 € to 7.75 € during the past year

What is the cash to sales ratio of Hopening?

The cash to sales ratio of Hopening is 0.26

What is the registered address of Hopening?

The registered address for Hopening is 4 rue Bernard Palissy, Puteaux, Ile-de-France, 92817

What is the Hopening website address?

The website address for Hopening is hopening.fr

Which industry sector does Hopening operate in?

Hopening operates in the Traditional Media sector

hankmanhub

hankmanhub 5分前

My impression is that during 2026 the focus shifted more toward matters such as label scope, manufacturing, product characterisation, post-approval obligations, and the overall regulatory framework surrounding this application.
Where do you get this from other than your own speculation. They

creakyhottie

creakyhottie 6分前

one transaction

jour_trader

jour_trader 6分前

Quick thought on Eliquis. I just realized something tonight. As of now Elite’s market is focused on US. Israel doesn’t really bring in much to say we’re geographically diversified. The US portion of Eliquis is not $27B from brand standpoint. That is the global market.
The US market for Eliqui

Vexari

It has to be lived

To understand

old.bitchute.com/video/U5jma0xHSsWP/ Its meaning

https://old.bitchute.com/video/U5jma0xHSsWP/
(3:40)

Just give me $1.50

Just give me $1.50 9分前

100 percent of shareholders are going to DEMAND The Rat's resignation on the upcoming conference call.

One hundred PHUCKIN percent.

Not aligned with long suffering retailers for many years now, it is as clear as day !

hardlesson

hardlesson 11分前

Same for you Z, regarding the hard work. Some of you guys never sleep. Ty. :)

Just give me $1.50

Just give me $1.50 14分前

So The Rat, as evidenced by HIMSELF in the quote below, has been working on the uplisting for 5+ months now.

Da fuq is the hold up?

Options continue to be acquisition, which is our number one focus. If it does not happen by 2026, then we will start doing the prep work f

Just give me $1.50

Just give me $1.50 16分前

This is your DAILY reminder to prepare your MIKAH questions for the upcoming MIKAH conference call.

Our goal on this board is to submit at least 100 QUESTIONS in total regarding The Mikah Scam.

June 15: 10-K filed after hours
June 16: Mikah conference call

DrivenByPain

DrivenByPain 17分前

Wrong ! No R/S Watch For Independent Director To Be Added 🤑SNTX🤑

It looks like we’ll have an update on the shareholder dividend VERY soon, along with additional acquisition and partnership developments currently in progress.

We also expect to begin addin

stoxjock

stoxjock 23分前

I really hope the "L1" Tranche pf RKT Shares are going to be utilized and that hopefully is to buy some Assets of WaMu and we get those shares by July 2nd week. Fingers Crossed!

GLTU & GLTA WaMu Escrow-Holders!

stoxjock

stoxjock 26分前

Ron,
Are the RE going into the WFC Trusts or US Bank's ones or both?
TIA & GLTU!

jondoeuk

jondoeuk 29分前

OT: 'A PRINTed GLA medicine that addresses the multi-organ impact of Fabry and deliver multi-year durability without the challenges of frequent dosing or viral vector-based delivery would be transformative for patients.' https://www.globenewswire.com/news-release/2026/05/12/3292599/0/en/addition-the

stoxjock

stoxjock 29分前

Husshh. Shhh.. Let Not the Word out Yet! Let us first get our WaMu 'Buckets' so that we Load up More of FnF...Lol!

1manband

1manband 30分前

If anyone is interested in a Whistleblower award for stock fraud, the SEC's program is a very high bar. Besides only paying once a monetary penalty is received by the Commission, the program also requires a long application process and any payments may come years after the tip is first given.

ScottishTexan

ScottishTexan 31分前

Search $vgls on X

getmoreshares

getmoreshares 32分前

lots of clown BS-- over 3/4 of the weekend posts-- Glad most of us do not waste our time reading them

skitahoe

skitahoe 35分前

The type of trial you're suggesting will never happen again, at least not with the DCVax's IMHO. The FDA and others are recognizing the benefits of treating all in a trial and letting the results go against the existing data for the disease in question. I believe that few trials in the future agai

Ridetherocket

Ridetherocket 39分前

Hold on , I'm obviously not as smart as you guys when it comes to this, BUT if it does an IPO all I will get is 1 share for every 23 I have now? So say I have 23,000 now, that becomes only 1000 after Ipo. Unless you have a million shares why in the world have I been holding on fnma for last six mt

Sammy boy

Sammy boy 42分前

Then we have Bill Pulte, I wish I could invest in these companies when the stock was trading near $13. Stock dips below $7 and the sleaze bag says nothing, tells you a lot about his character, nice guy!

gfp927z

gfp927z 43分前

Elton John -

https://youtu.be/8K5ecDiuQEE?list=RD8K5ecDiuQEE

---

delerious1

delerious1 45分前

"...it's an acronym." No it isn't.....er, an acronym....

DewDiligence

DewDiligence 52分前

Lilly also reported cases of dysesthesia, an abnormal sensation such as tingling or burning… IMO, this could turn out to be a pretty big impediment to commercial uptake (assuming regulatory approval). The dysesthesia issue was discussed on this board when LLY announced the topline results two weeks

meirluc

meirluc 52分前

Doc, if Flaskworks is not happening, why on earth is NWBO working to update the electrical infrastructure of the Grade C suite and complete the buildout of that suite?

As for whether Flaskworks is done or on the way is a question to be asked after that C suite work has been completed

GoodGuyBill

GoodGuyBill 56分前

Gary, normally I’d agree with you — in most cases, guys like Griffin write a inconsequential check, shrug it off, and the story ends. But the scale and duration of the misconduct here is so large, so well-documented, and so interconnected across multiple companies since 2017, that this isn’t just an

AnPac Bio Medical Science

Dateline resources

Kaken Pharmaceutical (PK)

Wool Industry Tria Alfa ...

1.75% 26apr2028

China Construction Bank

Nuveen Small Cap Select ...

7.875% PERM INT BEARING ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。